Australia is welcome innovative therapy for obesity: Retatrutide. This new dual compound – working on both GLP-1 and GIP receptors – shows significant efficacy in international studies, indicating meaningful reductions in weight. While availability hasn't occurred with TGA, many individuals struggling obesity could considering Retatrutide as po… Read More